MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jacamr/dlaf016

Медицинская библиотека · JAC-antimicrobial resistance · 2025

Host-response testing with MeMed BV in community-acquired pneumonia: an economic evaluation from the UK NHS perspective.

Gregg Emily, Graziadio Sara, Green William, Afonso Daniela, Garrett Monica, Watts Karina, Watkins Deborah, Carrol Enitan D, Cooke Jonathan, Felton Tim

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Community-acquired pneumonia (CAP) remains a leading cause of hospital admissions and mortality. A novel host-response test, MeMed BV (MMBV), has been developed for discriminating between bacterial and viral infection that could improve the clinical management of CAP.

OBJECTIVES

To evaluate the cost-effectiveness of using MMBV to guide antibiotic decisions in the clinical management of CAP in the UK.

METHODS

An economic model was developed to understand the incremental cost per person associated with the implementation of MMBV from the UK NHS perspective. A qualitative care pathway analysis was performed to inform the standard of care (SOC) and SOC plus MMBV (SOC + MMBV) clinical pathways captured in the model.

RESULTS

In the base case analysis, the SOC + MMBV strategy for a hypothetical cohort of 1000 patients (adults and children modelled independently) presenting to the emergency department with suspected CAP was estimated to provide total cost savings of £134 018 and £105 750 for adults and children, respectively. Cost savings were associated with reductions in total antibiotic treatment, the number of patients receiving additional diagnostic tests, and hospital admissions. Deterministic sensitivity analysis revealed that the specificity of SOC + MMBV and sensitivity of the SOC were primary drivers of the cost model for adults, whereas the specificity of SOC and SOC + MMBV were primary drivers for paediatrics.

CONCLUSIONS

Overall, the model predicts that the introduction of SOC + MMBV has the potential to be cost-saving and promote antimicrobial stewardship for both adult and paediatric CAP patients.

Для цитирования: Gregg Emily, Graziadio Sara, Green William, Afonso Daniela, Garrett Monica, Watts Karina, Watkins Deborah, Carrol Enitan D, Cooke Jonathan, Felton Tim. Host-response testing with MeMed BV in community-acquired pneumonia: an economic evaluation from the UK NHS perspective.. JAC-antimicrobial resistance. 2025. DOI: 10.1093/jacamr/dlaf016.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.